CDC’s ACIP Will Reconvene April 23 To Discuss Pause On J&J’s Vaccine

By Beth Wang / April 16, 2021 at 11:44 AM
The Centers for Disease Control and Prevention’s vaccine advisory committee will reconvene Friday (April 23) to discuss whether Johnson & Johnson’s COVID-19 vaccine is OK to use in the United States after vaccinations were paused in light of reports of rare but serious blood clots experienced by six people who received the shot. The meeting will be held Friday from 11 a.m. to 5 p.m. EST, according to CDC’s Advisory Committee on Immunization Practices website. ACIP members met earlier this...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.